Home
Agenda 2030 - List Of Indicators
Percentage Of Bloodstream Infections Due To Selected Antimicrobial-resistant Organisms
Indicator detail
3.d.2 Percentage of bloodstream infections due to selected antimicrobial-resistant organisms
Metadata
| Relevance/rationale of the indicator (resp. why the indicator was chosen to measure the target and how it is suitable for these purposes) | Antimicrobial resistance (AMR) is a global threat to health, livelihoods, food security and the achievement of many of the Sustainable Development Goals. Antibiotics, antivirals, antiparasitic agents and antifungals are increasingly ineffective owing to resistance developed through their excessive or inappropriate use, with serious consequences for human and animal health (terrestrial and aquatic), and plant health, and negative impacts on food production, the environment and the global economy. |
| Target value of the indicator and its evaluation | |
| Definition | Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. Presumptive methicillin-resistant S. aureus (MRSA) isolates as defined by oxacillin minimum inhibitory concentration (MIC) and cefoxitin disc diffusion tests according to current internationally recognized clinical breakpoints (e.g., EUCAST or CLSI). E. coli resistant to third generation cephalosporins: E. coli isolates that are resistant as defined by current internationally recognized clinical breakpoints for third generation cephalosporins (e.g., EUCAST or CLSI), specifically ceftriaxone or cefotaxime or ceftazidime. |
| Measuring unit | % |
| Indicator disaggregation | By selected antimicrobial-resistant organisms |
| Reference period (resp. the period to which the indicator relates) | Year |
| Related geographical area | CZ (NUTS 0) |
| Comment |
| Update periodicity | Annually |
| Time coverage since | 2017 |
| Time coverage until | 2023 |
| Time series available at the data provider since | 2017 |
| Data publication date (resp. the date when the data provider publishes (regularly) data; it is given in the format T + the number of days, months or years when T is the end of the reference period) | T+11m |
| Contact point - data provider - e-mail | helena.zemlickova@szu.cz |
| Contact point - data provider - name | Helena Žemličková |
| Data source | National Institute of Public Health (NIPH) |
| Data origin | European Antimicrobial Resistance Surveillance Network, ECDC https://www.ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc |
| Links to detailed metadata or methodology | https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-02.pdf |
| Links to international comparison |